T
The Cigna Group (CI)
NYQ – Real vaqt narxi. Valyuta: USD
298.49
+9.42 (3.26%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NYQ – Real vaqt narxi. Valyuta: USD
298.49
+9.42 (3.26%)
Yopilishda: May 12, 2026, 4:00 PM EDT
| Tarkibi | |
|---|---|
| 1.44% | Insayderlar egalik qilgan aksiyalar ulushi |
| 91.85% | Institusional investorlar egalik qilgan aksiyalar ulushi |
| 93.19% | Institusional investorlar egalik qilgan erkin aksiyalar ulushi |
| 2203 | Institusional investorlar soni |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 17.12M | 2026-03-31 | 6.47% | $5.05B |
| Vanguard Portfolio Management LLC | 6.16M | 2026-03-31 | 2.33% | $1.82B |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 8.39M | 2025-12-31 | 3.17% | $2.47B |
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 7.40M | 2025-12-31 | 2.80% | $2.18B |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 6.74M | 2025-12-31 | 2.55% | $1.99B |
| MFS SERIES TRUST I-MFS Value Fund | 5.60M | 2026-02-28 | 2.12% | $1.65B |
| iShares Trust-iShares Core S&P 500 ETF | 3.39M | 2026-03-31 | 1.28% | $998.53M |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 3.36M | 2026-03-31 | 1.27% | $991.91M |
| SPDR S&P 500 ETF TRUST | 3.25M | 2025-12-31 | 1.23% | $848.79M |
| SPDR S&P 500 ETF Trust | 3.25M | 2025-12-31 | 1.22% | $937.20M |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 3.14M | 2026-04-30 | 1.19% | $926.57M |
| VANGUARD INDEX FUNDS-Vanguard Value Index Fund | 2.46M | 2025-12-31 | 0.93% | $724.71M |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.98M | 2026-02-28 | 0.75% | $545.16M |
| SELECT SECTOR SPDR TRT-State Street Health Care Select Sector SPDR ETF | 1.91M | 2026-04-30 | 0.72% | $561.97M |
| JPMorgan Trust II-JPMorgan Equity Income Fund | 1.60M | 2025-12-31 | 0.60% | $470.40M |